Casandra
Casandra Test Code LC21339Version 1 (DRAFT)
Performing Lab
Prostate Cancer Profile II (Serial Monitor)
Clinical Use
Order TestUse
Monitor the course of prostate cancer, patient response to treatment, and disease recurrence
Special Instructions
Not provided.
Limitations
The results obtained from different assay methods or kits should not be used interchangeably due to variability in test methodologies. Additionally, these test results should not be interpreted as conclusive evidence of the presence or absence of malignant disease.
Test Details
Methodology
Immunoassay (ECLIA)
Biomarkers
2 components
Prostate Specific Antigen (PSA) • ECLIAProstatic Acid Phosphatase (PAP) • ECLIA
LOINC Codes
Result Codes
- 20420-6 - PACP Ser-mCnc
- 2857-1 - PSA SerPl-mCnc
- 80563-0 - Report
Result Turnaround Time
2-4 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Red-top tube or gel-barrier tube. Do not use acid phosphatase transport tube.
Storage Instructions
Refrigerated and frozen
Causes for Rejection
Plasma or whole blood specimen; hemolysis; frozen sample not received for PAP
Similar Tests
Other tests from different labs that may be relevant
Prostatic Acid Phosphatase (PAP)
Quest Diagnostics
Prostatic Acid Phosphatase, Serum
Mayo Clinic Lab
Prostatic Acid Phosphatase
ARUP Laboratories
Prostate Specific Antigen, Total
ARUP Laboratories
Prostate-Specific Antigen (PSA) Screen, Serum
Mayo Clinic Lab
Prostate-Specific Antigen (PSA) Ultrasensitive, Serum
Mayo Clinic Lab
Prostate-Specific Antigen (PSA) Diagnostic, Serum
Mayo Clinic Lab
Prostate Specific Antigen, Ultrasensitive
ARUP Laboratories
Prostate Specific Antigen, Complexed
ARUP Laboratories
Prostate Specific Antigen, Total - Medicare Screening
ARUP Laboratories